Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × FED × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

OTHER 129 INDUSTRY 4 NETWORK 2 NIH 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

sargramostim 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Exercise 3 Palliative Care 2 Methods 2 Leuprolide 2 Gelatin 2 Decision Support Techniques 2 Colonoscopy 2 Clofarabine 2 Cholecalciferol 2 ADI PEG20 2 talabostat 1 sulforaphane 1 apalutamide 1 abiraterone 1 Yoga 1 Water 1 Tretinoin 1 Topotecan 1 Thioctic Acid 1 Tablets 1 Surgical Instruments 1 Streptozocin 1 Social Work 1 Simvastatin 1 Selective Serotonin Reuptake Inhibitors 1 Rituximab 1 Resistance Training 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡